Safe Continuation of Apheresis during Pregnancy using the Double-Filtration Plasmapheresis Thermo Mode in a Pregnant Female with Familial Hypercholesterolemia: A Case Report
Journal of Atherosclerosis and Thrombosis · 2026
DOI: 10.5551/jat.65360 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2026. Verfasst von Yoshimasa Sakurabu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Plasmapheresis, Blood Component Removal, Pregnancy Complications. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Familial hypercholesterolemia (FH) is an inherited disorder characterized by elevated LDL cholesterol levels and an increased risk of early-onset atherosclerotic cardiovascular disease. In pregnant female with FH, apheresis is the preferred treatment because standard therapeutic agents such as statins are contraindicated during pregnancy. LDL adsorption therapy is commonly used; however, after 27 weeks of gestation, it is often switched to dual filtration plasma exchange (DFPP) due to the significant drop in blood pressure caused by bradykinin production. However, DFPP has limited ability to adapt to the increase in circulating plasma volume associated with pregnancy. Here we discuss the case of a 32-year-old female with homozygous FH who underwent different apheresis strategies during her pregnancies. In her first pregnancy, she continued LDL adsorption therapy using DFPP but ultimately delivered a small-for-gestational-age infant via cesarean section. For her second pregnancy, double-filtration plasmapheresis thermo mode, DF-thermo, was introduced to mitigate the limitations of DFPP and LDL adsorption therapies, such as hypotension during apheresis and albumin loss. By minimizing these complications, DF-thermo allowed for a successful delivery without compromising fetal growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences.
- Department of Obstetrics and Gynecology, Okayama University Hospital.
- Department of Clinical Engineering Center, Okayama University Hospital.
Zitieren
APA
Sakurabu, Y., Uchida, H. A., Okuyama, Y., Eto, E., Takasugi, K., Asakawa, T., Katayama, K., Okamoto, S., Onishi, Y., Matsuoka-Uchiyama, N., Fujihara, C., Tanaka, K., Takeuchi, H., Umebayashi, R., Tanabe, K., & Wada, J. (2026). Safe Continuation of Apheresis during Pregnancy using the Double-Filtration Plasmapheresis Thermo Mode in a Pregnant Female with Familial Hypercholesterolemia: A Case Report. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.65360
Vancouver
Sakurabu Y, Uchida HA, Okuyama Y, Eto E, Takasugi K, Asakawa T, et al. Safe Continuation of Apheresis during Pregnancy using the Double-Filtration Plasmapheresis Thermo Mode in a Pregnant Female with Familial Hypercholesterolemia: A Case Report. Journal of Atherosclerosis and Thrombosis. 2026. doi:10.5551/jat.65360
BibTeX
@article{Sakurabu2026,
author = {Sakurabu, Yoshimasa and Uchida, Haruhito A and Okuyama, Yuka and Eto, Eriko and Takasugi, Kanako and Asakawa, Tomohiko and Katayama, Katsuyoshi and Okamoto, Shugo and Onishi, Yasuhiro and Matsuoka-Uchiyama, Natsumi and Fujihara, Chihiro and Tanaka, Keiko and Takeuchi, Hidemi and Umebayashi, Ryoko and Tanabe, Katsuyuki and Wada, Jun},
title = {Safe Continuation of Apheresis during Pregnancy using the Double-Filtration Plasmapheresis Thermo Mode in a Pregnant Female with Familial Hypercholesterolemia: A Case Report},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2026},
doi = {10.5551/jat.65360}
}
EUVIMED